Growing cancer incidence and mortality worldwide demands development of accurate
biomarkers to perfect detection, diagnosis, prognostication and monitoring. Urologic …

Metastasis and resistance to therapy significantly contribute to cancer-related deaths.
Growing body of evidence suggest that altered expression of microRNAs (miRNAs) is one of …

MicroRNAs (miRNAs) are a type of non-coding RNAs with about~ 22nt nucleotides.
Increasing evidences have shown that miRNAs play critical roles in many human diseases …

MicroRNA (miRNA) is involved in the progression and metastasis of diverse human cancers,
including breast cancer, as strong evidence has been found that miRNAs can act as …

Malignant gliomas represent the most devastating group of brain tumors in adults, among
which glioblastoma multiforme (GBM) exhibits the highest malignancy rate. Despite …

Long non-coding RNAs (lncRNAs) have been implicated in a variety of biological processes
and dysregulated lncRNAs have demonstrated potential roles as biomarkers and …

Previous studies have reported aberrant expression of the miR-183-96-182 cluster in a
variety of tumors, which indicates its' diagnostic or prognostic value. However, a key …

Growing evidence indicates that microRNAs (miRNAs) play critical roles in the initiation and
progression of breast carcinoma (BC) and are promising diagnostic biomarkers. In the …

Approximately 15–20% of breast cancers (BC) show either membrane overexpression of
ErbB-2 (MErbB-2), a member of the ErbBs family of receptor tyrosine kinases, or ERBB2 …

Introduction Plasma microRNAs (miRNAs) are promising biomarkers for many forms of
cancer in humans; however, a fundamental concern is the lack of standardization in current …